Reducing long term ischaemic events in high-risk patients: the role of intensified antithrombotic treatment

Supported by an unrestricted educational grant from AstraZeneca

Chairpersons: C. Spaulding, P. Steg

Panellists: D. Capodanno, M. Gilard

Summary

Consult this session to learn more about the role of intensified antithrombotic treatment in improving cardiovascular outcomes in high-risk patients and how to implement this treatment.

Learning Objectives

To review the improved cardiovascular outcomes with antithrombotic drugs
To discuss the clinical strategy for treatment implementation

Presentations available when logged in:

How did I treat?
Secondary prevention with intensified antithrombotic treatment for which high-risk patients?
Session evaluation and key learnings

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Reducing long term ischaemic events in high-risk patients: the role of intensified antithrombotic treatment

Supported by an unrestricted educational grant from AstraZeneca

Learning Objectives

Log in or create account for free